Insider · CIK 0001870875
Staffan Encrantz
Files at SGHT (Sight Sciences, Inc.). First filing Nov 21, 2024, latest Jun 11, 2026.
In brief
Staffan Encrantz files SEC Form 4 as director and 10% owner at SGHT (Sight Sciences, Inc.). Since Nov 21, 2024, Staffan Encrantz has reported 6 open-market buys worth $3.5M and 1 open-market sell worth $2.1M, the latest filed on Jun 11, 2026.
A track record needs three past buys with six months of prices behind them; Staffan Encrantz has 1, so none is measured yet.
The newest scored trade: bought $69k of SGHT on Jun 10, 2026, filed Jun 11, 2026, scored 26 (weak). In the last 12 months: 2 buys worth $185k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SGHT: Sight Sciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | SGHTbuy Sight Sciences, Inc. | $69k 14,100 shares | +1% | +51% from low-47% from high | |
| 25Weak | SGHTbuy Sight Sciences, Inc. | $116k 13,958 shares | +1% | +301% from low-2% from high | |
| 47Moderate | SGHTbuy Sight Sciences, Inc. | $382k 90,525 shares | +7% | +103% from low-39% from high | |
| 47Moderate | SGHTbuy Sight Sciences, Inc. | $376k 98,782 shares | +9% | +77% from low-47% from high | |
| 43Moderate | SGHTbuy Sight Sciences, Inc. | $452k 128,189 shares | +12% | +65% from low-51% from high | |
| 51Moderate | Sight Sciences, Inc. | $2.1M 551,802 shares | +14% | - | |
| 50Moderate | SGHTsell Sight Sciences, Inc. | $2.1M 551,802 shares | -47% | - |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stock | +14,100 | $4.88 | $69k | 1,434,283 | Jun 11, 2026 |
| Jun 4, 2026 | SGHT Sight Sciences, Inc. | AGrant or award Common Stock | +28,261 | $0.00 | $0 | 1,420,183 | Jun 5, 2026 |
| Dec 16, 2025 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stock | +13,958 | $8.31 | $116k | 1,391,922 | Dec 18, 2025 |
| Jun 4, 2025 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stock | +21,674 | $4.17 | $90k | 1,278,161 | Jun 6, 2025 |
| Jun 5, 2025 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stock | +40,951 | $4.24 | $174k | 1,319,112 | Jun 6, 2025 |
| Jun 5, 2025 | SGHT Sight Sciences, Inc. | AGrant or award Common Stock | +30,952 | $0.00 | $0 | 1,350,064 | Jun 6, 2025 |
| Jun 6, 2025 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stock | +27,900 | $4.22 | $118k | 1,377,964 | Jun 6, 2025 |
| May 30, 2025 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stock | +42,753 | $3.67 | $157k | 1,200,458 | Jun 3, 2025 |
| Jun 2, 2025 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stock | +30,799 | $3.88 | $119k | 1,231,257 | Jun 3, 2025 |
| Jun 3, 2025 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stock | +25,230 | $3.97 | $100k | 1,256,487 | Jun 3, 2025 |
| May 27, 2025 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stock | +41,346 | $3.44 | $142k | 1,070,862 | May 29, 2025 |
| May 28, 2025 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stock | +26,715 | $3.52 | $94k | 1,097,577 | May 29, 2025 |
| May 29, 2025 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stock | +60,128 | $3.59 | $216k | 1,157,705 | May 29, 2025 |
| Mar 10, 2025 | SGHT Sight Sciences, Inc. | JOther Common Stockindirect: See footnote | +120,000 | $2.53 | $304k | 4,693,920 | Mar 13, 2025 |
| Mar 11, 2025 | SGHT Sight Sciences, Inc. | JOther Common Stockindirect: See footnote | +150,000 | $2.71 | $407k | 4,843,920 | Mar 13, 2025 |
| Mar 12, 2025 | SGHT Sight Sciences, Inc. | JOther Common Stockindirect: See footnote | +243,000 | $2.77 | $673k | 5,086,920 | Mar 13, 2025 |
| Nov 21, 2024 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stockindirect: See footnote | -551,802 | $3.73 | $2.1M | 632,456 | Nov 21, 2024 |
| Nov 21, 2024 | SGHT Sight Sciences, Inc. | POpen-market purchase Common Stockindirect: See footnote | +551,802 | $3.73 | $2.1M | 4,573,920 | Nov 21, 2024 |
Questions about Staffan Encrantz
Answered from the filings on this page, as of the latest one.
Is Staffan Encrantz buying or selling?
In the last 12 months Staffan Encrantz reported 2 open-market buys worth $185k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $69k of SGHT on Jun 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Staffan Encrantz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Staffan Encrantz has 1.
Where does Staffan Encrantz file Form 4?
Staffan Encrantz has filed Form 4 at SGHT (Sight Sciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.